Literature DB >> 28521338

Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance.

Shiri Navon-Venezia1, Kira Kondratyeva1, Alessandra Carattoli2.   

Abstract

Klebsiella pneumoniae is an important multidrug-resistant (MDR) pathogen affecting humans and a major source for hospital infections associated with high morbidity and mortality due to limited treatment options. We summarize the wide resistome of this pathogen, which encompasses plentiful chromosomal and plasmid-encoded antibiotic resistance genes (ARGs). Under antibiotic selective pressure, K. pneumoniae continuously accumulates ARGs, by de novo mutations, and via acquisition of plasmids and transferable genetic elements, leading to extremely drug resistant (XDR) strains harboring a 'super resistome'. In the last two decades, numerous high-risk (HiR) MDR and XDR K. pneumoniae sequence types have emerged showing superior ability to cause multicontinent outbreaks, and continuous global dissemination. The data highlight the complex evolution of MDR and XDR K. pneumoniae, involving transfer and spread of ARGs, and epidemic plasmids in highly disseminating successful clones. With the worldwide catastrophe of antibiotic resistance and the urgent need to identify the main pathogens that pose a threat on the future of infectious diseases, further studies are warranted to determine the epidemic traits and plasmid acquisition in K. pneumoniae. There is a need for future genomic and translational studies to decipher specific targets in HiR clones to design targeted prevention and treatment. © FEMS 2017. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  antibiotic resistance; epidemic plasmids; extremely drug resistant (XDR); high-risk clones; mobile genetic elements (MGEs); resistome

Mesh:

Substances:

Year:  2017        PMID: 28521338     DOI: 10.1093/femsre/fux013

Source DB:  PubMed          Journal:  FEMS Microbiol Rev        ISSN: 0168-6445            Impact factor:   16.408


  222 in total

1.  Evidence of Sharing of Klebsiella pneumoniae Strains between Healthy Companion Animals and Cohabiting Humans.

Authors:  Cátia Marques; Adriana Belas; Catarina Aboim; Patrícia Cavaco-Silva; Graça Trigueiro; Luís Telo Gama; Constança Pomba
Journal:  J Clin Microbiol       Date:  2019-05-24       Impact factor: 5.948

2.  Structure, activity and thermostability investigations of OXA-163, OXA-181 and OXA-245 using biochemical analysis, crystal structures and differential scanning calorimetry analysis.

Authors:  Bjarte Aarmo Lund; Ane Molden Thomassen; Trine Josefine Olsen Carlsen; Hanna Kirsti S Leiros
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2017-10-02       Impact factor: 1.056

3.  Octapeptin C4 and polymyxin resistance occur via distinct pathways in an epidemic XDR Klebsiella pneumoniae ST258 isolate.

Authors:  Miranda E Pitt; Minh Duc Cao; Mark S Butler; Soumya Ramu; Devika Ganesamoorthy; Mark A T Blaskovich; Lachlan J M Coin; Matthew A Cooper
Journal:  J Antimicrob Chemother       Date:  2019-03-01       Impact factor: 5.790

Review 4.  Antimicrobial Resistance in ESKAPE Pathogens.

Authors:  David M P De Oliveira; Brian M Forde; Timothy J Kidd; Patrick N A Harris; Mark A Schembri; Scott A Beatson; David L Paterson; Mark J Walker
Journal:  Clin Microbiol Rev       Date:  2020-05-13       Impact factor: 26.132

5.  α-Triazolylboronic Acids: A Promising Scaffold for Effective Inhibitors of KPCs.

Authors:  Maria Luisa Introvigne; Magdalena A Taracila; Fabio Prati; Emilia Caselli; Robert A Bonomo
Journal:  ChemMedChem       Date:  2020-06-22       Impact factor: 3.466

Review 6.  Population genomics of Klebsiella pneumoniae.

Authors:  Kelly L Wyres; Margaret M C Lam; Kathryn E Holt
Journal:  Nat Rev Microbiol       Date:  2020-02-13       Impact factor: 60.633

7.  Morpholino oligomers tested in vitro, in biofilm and in vivo against multidrug-resistant Klebsiella pneumoniae.

Authors:  Bruce L Geller; Lixin Li; Fabian Martinez; Erin Sully; Carolyn R Sturge; Seth M Daly; Christine Pybus; David E Greenberg
Journal:  J Antimicrob Chemother       Date:  2018-06-01       Impact factor: 5.790

8.  Multifaceted mechanisms of colistin resistance revealed by genomic analysis of multidrug-resistant Klebsiella pneumoniae isolates from individual patients before and after colistin treatment.

Authors:  Yan Zhu; Irene Galani; Ilias Karaiskos; Jing Lu; Su Mon Aye; Jiayuan Huang; Heidi H Yu; Tony Velkov; Helen Giamarellou; Jian Li
Journal:  J Infect       Date:  2019-07-30       Impact factor: 6.072

9.  Klebsiella pneumoniae type VI secretion system-mediated microbial competition is PhoPQ controlled and reactive oxygen species dependent.

Authors:  Daniel Storey; Alan McNally; Mia Åstrand; Joana Sa-Pessoa Graca Santos; Isabel Rodriguez-Escudero; Bronagh Elmore; Leyre Palacios; Helina Marshall; Laura Hobley; Maria Molina; Victor J Cid; Tiina A Salminen; Jose A Bengoechea
Journal:  PLoS Pathog       Date:  2020-03-19       Impact factor: 6.823

10.  RNA markers for ultra-rapid molecular antimicrobial susceptibility testing in fluoroquinolone-treated Klebsiella pneumoniae.

Authors:  Xi Yang; Marjan M Hashemi; Nadya Andini; Michelle M Li; Shuzhen Kuang; Karen C Carroll; Tza-Huei Wang; Samuel Yang
Journal:  J Antimicrob Chemother       Date:  2020-07-01       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.